Amp Volatility Score
Catalyst Info & Data Links
TITLE: Altimmune's NasoShield Vaccine for Anthrax Phase 1b Trial Begins
WHAT IS THE NEXT CATALYST EVENT?
Phase 1b Data
WHEN WILL THE EVENT (OR DID THE EVENT) OCCUR?
08-12-2020 Slide Deck (Slides 18-20)
MECHANISM OF ACTION
An intranasal vaccine designed to provide rapid, stable protection against anthrax after a single administration. It is being developed with the support of the U.S. Biomedical Advanced Research and Development Authority, (“BARDA”) for post-exposure prophylaxis against anthrax following exposure to aerosolized B. anthracis spores.
Updated by MV
#Anthrax #ALT #ALTIMMUNE #Vaccine
Prior Data (click to view full image)
Trial Design / Revenue (click to view full image)
See What The Community Is Saying - Click To See Full Post